Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial.

Christensen A, Christrup LL, Fabricius PE, Chrostowska M, Wronka M, Narkiewicz K, Hansen EH.

J Hypertens. 2010 Jan;28(1):194-200. doi: 10.1097/HJH.0b013e328331b718.

PMID:
19770778
[PubMed - indexed for MEDLINE]
2.

Sustained antihypertensive activity of telmisartan compared with valsartan.

Lacourcière Y, Krzesinski JM, White WB, Davidai G, Schumacher H.

Blood Press Monit. 2004 Aug;9(4):203-10.

PMID:
15311147
[PubMed - indexed for MEDLINE]
3.
4.

Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial.

Wetzels GE, Nelemans PJ, Schouten JS, Dirksen CD, van der Weijden T, Stoffers HE, Janknegt R, de Leeuw PW, Prins MH.

Am J Hypertens. 2007 Feb;20(2):119-25.

PMID:
17261454
[PubMed - indexed for MEDLINE]
5.

A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.

Lacourcière Y, Neutel JM, Davidai G, Koval S.

Am J Hypertens. 2006 Jan;19(1):104-12.

PMID:
16461201
[PubMed - indexed for MEDLINE]
6.

Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.

White WB, Lacourciere Y, Davidai G.

Am J Hypertens. 2004 Apr;17(4):347-53.

PMID:
15062889
[PubMed - indexed for MEDLINE]
7.

A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.

Littlejohn T, Mroczek W, Marbury T, VanderMaelen CP, Dubiel RF.

Can J Cardiol. 2000 Sep;16(9):1123-32. English, French.

PMID:
11021956
[PubMed - indexed for MEDLINE]
8.

Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.

Düsing R, Handrock R, Klebs S, Tousset E, Vrijens B.

J Hypertens. 2009 Apr;27(4):894-901. doi: 10.1097/HJH.0b013e328323f9be.

PMID:
19300114
[PubMed - indexed for MEDLINE]
9.

Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.

White WB, Weber MA, Davidai G, Neutel JM, Bakris GL, Giles T.

Blood Press Monit. 2005 Jun;10(3):157-63.

PMID:
15923818
[PubMed - indexed for MEDLINE]
10.

Novel description of the 24-hour circadian rhythms of brachial versus central aortic blood pressure and the impact of blood pressure treatment in a randomized controlled clinical trial: The Ambulatory Central Aortic Pressure (AmCAP) Study.

Williams B, Lacy PS, Baschiera F, Brunel P, Düsing R.

Hypertension. 2013 Jun;61(6):1168-76. doi: 10.1161/HYPERTENSIONAHA.111.00763. Epub 2013 Apr 29.

PMID:
23630950
[PubMed - indexed for MEDLINE]
Free Article
11.

Relationship between the frequency of blood pressure self-measurement and blood pressure reduction with antihypertensive therapy : results of the OLMETEL (OLMEsartan TELemonitoring blood pressure) study.

Ewald S, vor dem Esche J, Uen S, Neikes F, Vetter H, Mengden T.

Clin Drug Investig. 2006;26(8):439-46.

PMID:
17163276
[PubMed - indexed for MEDLINE]
12.

Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study.

Santschi V, Rodondi N, Bugnon O, Burnier M.

Eur J Intern Med. 2008 Oct;19(6):427-34. doi: 10.1016/j.ejim.2007.12.007. Epub 2008 Feb 11.

PMID:
18848176
[PubMed - indexed for MEDLINE]
13.

Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study.

Márquez-Contreras E, Martell-Claros N, Gil-Guillén V, de la Figuera-Von Wichmann M, Casado-Martínez JJ, Martin-de Pablos JL, Figueras M, Galera J, Serra A; Compliance Group of the Spanish Society of Hypertension (SEE).

J Hypertens. 2006 Jan;24(1):169-75.

PMID:
16331115
[PubMed - indexed for MEDLINE]
14.

Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension.

White WB, Littlejohn TW, Majul CR, Oigman W, Olvera R, Seeber M, Schumacher H, Mancia G.

Blood Press Monit. 2010 Aug;15(4):205-12. doi: 10.1097/MBP.0b013e32833c5722.

PMID:
20613496
[PubMed - indexed for MEDLINE]
15.

ABPM comparison of the anti-hypertensive profiles of telmisartan and enalapril in patients with mild-to-moderate essential hypertension.

Amerena J, Pappas S, Ouellet JP, Williams L, O'Shaughnessy D.

J Int Med Res. 2002 Nov-Dec;30(6):543-52.

PMID:
12526280
[PubMed - indexed for MEDLINE]
16.

Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.

Hermida RC, Ayala DE, Mojón A, Fernández JR.

Chronobiol Int. 2013 Mar;30(1-2):315-27. doi: 10.3109/07420528.2012.701534. Epub 2012 Oct 25.

PMID:
23181712
[PubMed - indexed for MEDLINE]
17.

Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET).

Mancia G, Parati G, Bilo G, Gao P, Fagard R, Redon J, Czuriga I, Polák M, Ribeiro JM, Sanchez R, Trimarco B, Verdecchia P, van Mieghem W, Teo K, Sleight P, Yusuf S.

Hypertension. 2012 Dec;60(6):1400-6. doi: 10.1161/HYPERTENSIONAHA.112.199562. Epub 2012 Oct 15.

PMID:
23071122
[PubMed - indexed for MEDLINE]
Free Article
18.

Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting.

White WB, Giles T, Bakris GL, Neutel JM, Davidai G, Weber MA.

Am Heart J. 2006 Jan;151(1):176-84.

PMID:
16368314
[PubMed - indexed for MEDLINE]
19.
20.

The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care.

Rinfret S, Lussier MT, Peirce A, Duhamel F, Cossette S, Lalonde L, Tremblay C, Guertin MC, LeLorier J, Turgeon J, Hamet P; LOYAL Study Investigators.

Circ Cardiovasc Qual Outcomes. 2009 May;2(3):170-7. doi: 10.1161/CIRCOUTCOMES.108.823765. Epub 2009 May 5.

PMID:
20031834
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk